Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Top Stories > Fresenius Medical shares at 12-year low as labour costs weigh on profit
    Top Stories

    Fresenius Medical shares at 12-year low as labour costs weigh on profit

    Published by Jessica Weisman-Pitts

    Posted on July 28, 2022

    3 min read

    Last updated: February 5, 2026

    This image features products from Fresenius and Fresenius Medical Care displayed during their annual news conference. It highlights the company's challenges as shares hit a 12-year low due to rising labor costs and profit concerns.
    Fresenius Medical Care annual news conference showcasing products amid profit decline - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:insurancehealthcare expenditurefinancial crisisinvestmentcorporate governance

    By Ludwig Burger and Riham Alkousaa

    (Reuters) -Shares in the world’s largest kidney dialysis provider Fresenius Medical Care (FMC) plunged more than 12% to a 12-year low on Thursday after it cut its earnings outlook as costs surge and a U.S. staff shortage leaves it scrambling for nurses.

    In an unscheduled statement late on Wednesday, FMC flagged a decline in net income approaching 20% this year and withdrew its 2025 targets. It also said it expected sales growth at the lower end of the previous forecast range.

    Most of its U.S. patients are covered by state-run insurer Medicare, with lump-sum reimbursements per patient that only get adjusted to cost inflation with a two-year delay, the chief executive of FMC parent Fresenius, Stephan Sturm, said on an analyst call.

    FMC finance chief Helen Giza said the group, which now pays a premium to temporary staffing agencies, hopes to find enough permanent renal nurses again during the first half of next year.

    “We’re hearing anecdotally that people are being paid $200 an hour just to kind of get into these agencies,” Giza told analysts in a call. “This perfect storm that hit us in Q2, we really have to work our way out of.”

    The higher costs came after U.S. patient numbers declined during the pandemic because many kidney disease sufferers succumbed to COVID-19.

    Parent Fresenius, a diversified healthcare group, said it expected group net income to ease in a “low-to-mid single-digit percentage range” due to the decline at FMC, prompting its shares to fall 8.4% to a two-year low.

    It also expects group sales to grow by a similar degree in 2022, down from its previous forecast of a mid-single-digit percentage range.

    Fresenius, which also runs hospitals, makes generic drugs and helps plan hospital construction projects, reported a 5% drop in net income to 450 million euros ($458.96 million) while group revenue rose by 8% to 10.2 billion euros.

    FMC said increased staff training costs, higher turnover rates and growing reliance on contract labour pushed up costs further, in addition to non-wage cost and supply chain disruptions which also took a toll on earnings.

    It said it no longer expected to achieve organic revenue growth in North American health care services this year.

    “Although the company expects many of the factors behind this deterioration in near-term outlook to be temporary, we do not think this will come as much comfort to investors,” analysts at brokerage Berenberg said in a note.

    FMC’s net income fell by 33% in the second quarter year-on-year to 147 million euros, despite a 10% rise in revenue in the quarter, preliminary results showed.

    The company said new Chief Executive Carla Kriwet would take over from Rice Powell, who is retiring on Oct. 1, earlier than previously planned.

    In February, parent Fresenius increased its cost savings target to at least 150 million euros per year after tax, up from a previous goal of more than 100 million euros.

    Fresenius CEO Sturm said this year that FMC could be sold, but only if a very attractive price was offered. He said on Thursday that view had not changed but any bid for now appeared less likely.

    He also confirmed the company was looking for external investors to help finance a takeover or merger involving hospitals unit Helios, though Fresenius intends to keep the majority of shares.

    ($1 = 0.9805 euros)

    (Reporting by Ludwig Burger and Riham Alkousaa in Berlin; Additional reporting by Milla Nissi and Marie Mannes; Editing by David Gregorio, Jan Harvey and Mark Potter)

    Frequently Asked Questions about Fresenius Medical shares at 12-year low as labour costs weigh on profit

    1What is net income?

    Net income is the total profit of a company after all expenses, taxes, and costs have been deducted from total revenue. It is a key indicator of a company's profitability.

    2What is a staffing agency?

    A staffing agency is a company that matches employers with employees. They help businesses find temporary or permanent staff and often manage the hiring process.

    3What is organic revenue growth?

    Organic revenue growth is the increase in a company's sales generated from its existing operations, excluding any revenue from acquisitions or mergers.

    More from Top Stories

    Explore more articles in the Top Stories category

    Image for Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Image for Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Image for Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Image for Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Image for Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Image for Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Image for Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Image for PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    Image for A Notable Update for Employee Health Benefits:
    A Notable Update for Employee Health Benefits:
    Image for Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Image for Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Image for ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    View All Top Stories Posts
    Previous Top Stories PostMotor racing-Vettel announces retirement, says his goals have shifted
    Next Top Stories PostBiden begins fifth call with China’s Xi, looking to tamp down Taiwan tension